Goldman Sachs’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Goldman Sachs’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-284,911	Closed	-$28.7M	–	7572
2014 Q4	$28.7M	Sell	284,911 -7,534	-3%	-$586K	0.01%	1556
2014 Q3	$19.4M	Buy	292,445 +13,507	+5%	+$887K	0.01%	1805
2014 Q2	$19.5M	Sell	278,938 -38,627	-12%	-$2.63M	0.01%	1801
2014 Q1	$23.2M	Buy	317,565 +33,949	+12%	+$2.53M	0.01%	1647
2013 Q4	$19.5M	Sell	283,616 -279,074	-50%	-$18.1M	0.01%	1761
2013 Q3	$35.8M	Sell	562,690 -92,952	-14%	-$5.62M	0.01%	1200
2013 Q2	$31.7M	Buy	+655,642	New	+$32.2M	0.01%	1198

Goldman Sachs's CBST Position: Q1 2015 in Review

Goldman Sachs sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 284,911 shares — an estimated $28.7M sold.

Goldman Sachs first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $35.8M in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Goldman Sachs reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Goldman Sachs sold 284,911 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $28.7M.
Goldman Sachs first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Goldman Sachs's CUBIST PHARMACEUTICALS INC position peaked at $35.8M in Q3 2013.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.